Old Web
English
Sign In
Acemap
>
authorDetail
>
Anurag Pyasi
Anurag Pyasi
Sulbactam
Intensive care medicine
Ceftriaxone
Medicine
Meropenem
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis
2018
Open Forum Infectious Diseases
Pankaj Mandale
Mohd Amin Mir
Saransh Chaudhary
Manu Chaudhary
Rajeev Sood
N. S. Patil
Salil Narang
Anurag Pyasi
Mohammad Shameem
Other Principal Investigators
Show All
Source
Cite
Save
Citations (0)
1373. Activity of Ceftriaxone–Sulbactam–EDTA Against Multi-Drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) Collected from Various Hospitals in India
2018
Open Forum Infectious Diseases
Ruchi Girotra
Anurag Pyasi
Manu Chaudhary
N. S. Patil
Mohd Amin Mir
Saransh Chaudhary
Pankaj Mandale
Other Principle Investigators
Show All
Source
Cite
Save
Citations (1)
1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double-Blind Clinical Trial in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis)
2018
Open Forum Infectious Diseases
Mohd Amin Mir
Saransh Chaudhary
Manu Chaudhary
Anurag Pyasi
N. S. Patil
Ruchi Girotra
Salil Narang
Nazish Fatima
Other Principal Investigators
Show All
Source
Cite
Save
Citations (0)
1